F. Riches

Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity.

P. Talmud, G. Watts, F. V. van Bockxmeer, 2000, Journal of lipid research.

Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.

P. Talmud, G. Watts, F. V. van Bockxmeer, 1998, Journal of lipid research.

Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity

F. Riches, G. Watts, R. Naoumova, 1998, International Journal of Obesity.

DETERMINANTS OF THE KINETICS OF VERY LOW‐DENSITY LIPOPROTEIN APOLIPOPROTEIN B‐100 IN NON‐OBESE MEN

G. Watts, K. Croft, F. Riches, 1997, Clinical and experimental pharmacology & physiology.

Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man.

G. Watts, K. Croft, R. Naoumova, 1997, Atherosclerosis.

Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men.

G. Watts, S. Herrmann, F. Riches, 2000, QJM : monthly journal of the Association of Physicians.

Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.

G. Watts, R. Naoumova, P. Barrett, 1999, The Journal of clinical endocrinology and metabolism.

Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.

G. Watts, K. Croft, R. Naoumova, 1997, The American journal of physiology.